MAP1B and renal pelvis/ureter urothelial carcinoma: In summary, the present study demonstrated that MAP1B overexpression was not only an indicator of unfavorable clinicopathological parameters, but also an independent prognostic factor able to predict poor DSS and MFS rates in patients with UTUC or UBUC.